Matches in Wikidata for { <http://www.wikidata.org/entity/Q56962737> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q56962737 description "article published in 2015" @default.
- Q56962737 description "article scientifique publié en 2015" @default.
- Q56962737 description "im Dezember 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q56962737 description "wetenschappelijk artikel" @default.
- Q56962737 description "наукова стаття, опублікована в грудні 2014" @default.
- Q56962737 name "Effect of Exogenous Intravenous Administrations of GLP-1 and/or GIP on Circulating Pro-Atrial Natriuretic Peptide in Subjects With Different Stages of Glucose Tolerance: Figure 1" @default.
- Q56962737 name "Effect of Exogenous Intravenous Administrations of GLP-1 and/or GIP on Circulating Pro-Atrial Natriuretic Peptide in Subjects With Different Stages of Glucose Tolerance: Figure 1" @default.
- Q56962737 type Item @default.
- Q56962737 label "Effect of Exogenous Intravenous Administrations of GLP-1 and/or GIP on Circulating Pro-Atrial Natriuretic Peptide in Subjects With Different Stages of Glucose Tolerance: Figure 1" @default.
- Q56962737 label "Effect of Exogenous Intravenous Administrations of GLP-1 and/or GIP on Circulating Pro-Atrial Natriuretic Peptide in Subjects With Different Stages of Glucose Tolerance: Figure 1" @default.
- Q56962737 altLabel "Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance" @default.
- Q56962737 altLabel "Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance" @default.
- Q56962737 prefLabel "Effect of Exogenous Intravenous Administrations of GLP-1 and/or GIP on Circulating Pro-Atrial Natriuretic Peptide in Subjects With Different Stages of Glucose Tolerance: Figure 1" @default.
- Q56962737 prefLabel "Effect of Exogenous Intravenous Administrations of GLP-1 and/or GIP on Circulating Pro-Atrial Natriuretic Peptide in Subjects With Different Stages of Glucose Tolerance: Figure 1" @default.
- Q56962737 P1433 Q56962737-49110A27-71D6-428B-9730-F50EEC37182C @default.
- Q56962737 P1476 Q56962737-0DDC0088-7E40-4049-B4A6-D3D97CCEFDEF @default.
- Q56962737 P1476 Q56962737-C367B32E-7F65-4985-8C27-558DCD50E35E @default.
- Q56962737 P2093 Q56962737-0F71E6BF-F383-4622-829E-7194B982FB1D @default.
- Q56962737 P2093 Q56962737-13F8CEDB-3652-4CBF-B9DA-129350FAAC64 @default.
- Q56962737 P2093 Q56962737-187D38AA-F50A-4D6C-84AA-0C50556DDA6B @default.
- Q56962737 P2093 Q56962737-5CE26B88-1932-4FEA-90E1-839F753A3E01 @default.
- Q56962737 P2093 Q56962737-6180F063-BB9D-4E4E-95F0-A7A3109BE3C6 @default.
- Q56962737 P2093 Q56962737-8A0819C5-5E42-4889-BBB6-05516D0A7672 @default.
- Q56962737 P2093 Q56962737-9B377288-0C23-4E0C-A52E-A8BB4A11DC7B @default.
- Q56962737 P2093 Q56962737-A2FCFB2B-8EC2-43C5-9A5C-327C259D8304 @default.
- Q56962737 P2093 Q56962737-AE9C026E-6D0E-46FB-BF42-A3C038736E12 @default.
- Q56962737 P2093 Q56962737-D6CF6706-9F6A-4CBD-9D15-AAC7BB60C9FA @default.
- Q56962737 P2093 Q56962737-E971165C-ED0C-49D4-AE11-1FD5FE1261DE @default.
- Q56962737 P304 Q56962737-09485C6E-12F7-4F9E-AF4A-298B70F288AE @default.
- Q56962737 P304 Q56962737-D3B05E7F-CB3F-472F-8CF3-4E17110B5059 @default.
- Q56962737 P31 Q56962737-45EE9D37-BEF7-44E7-8034-D76398F1179D @default.
- Q56962737 P356 Q56962737-C72B5FF6-C15D-4ADF-A7DE-63E48735221E @default.
- Q56962737 P407 Q56962737-01A10C32-BD2A-4413-AE09-540AFA3031E0 @default.
- Q56962737 P433 Q56962737-B8B9CFC7-D369-4EDE-A64C-DC3053D1814F @default.
- Q56962737 P478 Q56962737-EEA6ADED-CBD4-49CC-8447-0856F3FE76AA @default.
- Q56962737 P50 Q56962737-36286AF7-A897-41D2-B87B-49FA4331439B @default.
- Q56962737 P50 Q56962737-8124E84D-EF05-4582-A7EA-70F2BC64702D @default.
- Q56962737 P50 Q56962737-9AFA9C6C-C326-4A17-B07A-685F02FF1F2F @default.
- Q56962737 P50 Q56962737-C7CA0856-21AE-4D49-8BFF-5914E59C963D @default.
- Q56962737 P577 Q56962737-3293478B-D3F6-4ABA-B727-2F08A82CBB49 @default.
- Q56962737 P577 Q56962737-ACD42449-4247-4FA6-81C5-FF0557BB9DD9 @default.
- Q56962737 P698 Q56962737-7822257C-04A7-4AAA-A0B7-5D232EB0DD40 @default.
- Q56962737 P921 Q56962737-d9c2dbe1-47b1-41e6-9e86-341a19f2b69b @default.
- Q56962737 P356 DC14-1452 @default.
- Q56962737 P698 25538323 @default.
- Q56962737 P1433 Q5270111 @default.
- Q56962737 P1476 "Effect of Exogenous Intravenous Administrations of GLP-1 and/or GIP on Circulating Pro-Atrial Natriuretic Peptide in Subjects With Different Stages of Glucose Tolerance: Figure 1" @default.
- Q56962737 P1476 "Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance" @default.
- Q56962737 P2093 "Andrea Sparwasser" @default.
- Q56962737 P2093 "Andreas Bergmann" @default.
- Q56962737 P2093 "Andreas F H Pfeiffer" @default.
- Q56962737 P2093 "Ayman M Arafat" @default.
- Q56962737 P2093 "Ayman M. Arafat" @default.
- Q56962737 P2093 "Michael A Nauck" @default.
- Q56962737 P2093 "Michael A. Nauck" @default.
- Q56962737 P2093 "Natalia Rudovich" @default.
- Q56962737 P2093 "Olga Pivovarova" @default.
- Q56962737 P2093 "Wolfram Doehner" @default.
- Q56962737 P2093 "Özlem Gögebakan" @default.
- Q56962737 P304 "e7-8" @default.
- Q56962737 P304 "e7-e8" @default.
- Q56962737 P31 Q13442814 @default.
- Q56962737 P356 "10.2337/DC14-1452" @default.
- Q56962737 P407 Q1860 @default.
- Q56962737 P433 "1" @default.
- Q56962737 P478 "38" @default.
- Q56962737 P50 Q30310195 @default.
- Q56962737 P50 Q53743708 @default.
- Q56962737 P50 Q56998337 @default.
- Q56962737 P577 "2014-12-23T00:00:00Z" @default.
- Q56962737 P577 "2015-01-01T00:00:00Z" @default.
- Q56962737 P698 "25538323" @default.
- Q56962737 P921 Q37525 @default.